Facilitated By

San Antonio Medical Foundation

A PHASE 3, OPEN LABEL EXTENSION STUDY OF TIRASEMTIV FOR PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) WHO COMPLETED VITALITY ALS (CY 4031)

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Jackson,Carlayne E
Funded by
CYTOKINETICS, INC
Research Start Date
Status
Active
Clinical Care
Drug Discovery
Neuroscience